查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1593908

MRI 導引神經外科消融市場：按產品、最終用戶分類 - 全球預測 2025-2030 年

MRI Guided Neurosurgical Ablation Market by Product (Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems), End User (Ambulatory Surgical Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年MRI導引神經外科消融市場價值為38.9億美元，預計2024年將達到40.7億美元，複合年成長率為4.84%，到2030年將達到54.2億美元，預計將達到1000萬美元。

MRI引導的神經外科消融的範圍涉及利用MRI技術指導微創手術切除或切除腦組織。事實證明，這項技術至關重要，因為它可以精確定位疾病狀態，減少對周圍健康組織的潛在損害，從而改善患者的治療效果並縮短康復時間。其應用範圍廣泛，包括癲癇、腦腫瘤和帕金森氏症等神經系統疾病，最終用途主要在醫院、專科診所和研究機構。關鍵的成長要素包括神經系統疾病的盛行率不斷上升、對微創手術的需求不斷增加，以及提高準確性和安全性的 MRI 技術的進步。隨著醫療保健基礎設施的發展和人口老化的擴大，市場成長機會也隨之擴大。增強影像解讀和人工智慧整合以實現個人化治療計劃是顯示出創新潛力的領域。

主要市場統計
基準年[2023] 38.9億美元
預測年份 [2024] 40.7億美元
預測年份 [2030] 54.2億美元
複合年成長率（%） 4.84%

然而，一些限制和挑戰可能會阻礙市場成長，例如設備成本高以及對能夠操作複雜技術的熟練專業人員的需求。此外，監管和報銷挑戰可能會阻礙市場的快速滲透，特別是在醫療保健系統低度開發的新興市場。市場競爭激烈，主要企業在研發上投入大量資金，需要不斷創新才能保持競爭力。抓住新市場機會的建議包括投資人工智慧主導平台的開發、夥伴關係以擴大技術獲取，以及擴大臨床試驗計劃以檢驗新的治療應用。重點教育醫學界和患者了解 MRI 導引手術的好處可以提高採用率。創新的重點是提高 MRI 導引消融的手術效率、成本效益和結果。永續成長也需要前瞻性的方法來克服監管障礙並解決報銷問題。鑑於這些動態，預計市場將繼續快速發展，其特點是技術進步和更多地區的採用。

市場動態：快速發展的 MRI 導引神經外科消融市場的關鍵市場洞察

供需的動態交互作用正在改變 MRI 導引的神經外科消融市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 由於全球人口老化迅速增加，腦腫瘤的盛行率不斷增加
    • 微創神經外科手術的採用迅速增加
    • 提高患者對腦部疾病診斷和治療的認知
  • 市場限制因素
    • MRI 導引的神經外科消融相關的高成本
  • 市場機會
    • 新興國家醫療保健支出快速成長
    • 與神經外科消融相關的技術進步和研究活動的增加
  • 市場挑戰
    • 缺乏熟練人才

波特五力：駕馭 MRI 導引神經外科消融市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解 MRI 導引神經外科消融市場的外部影響

外部宏觀環境因素在塑造 MRI 導引神經外科消融市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解 MRI 導引神經外科消融市場的競爭格局

對 MRI 導引神經外科消融市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 MRI 導引神經外科消融市場供應商的績效評估

FPNV 定位矩陣是評估 MRI 導引神經外科消融市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了 MRI 導引神經外科消融市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對 MRI 導引的神經外科消融市場進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 隨著世界人口迅速老化，腦腫瘤的發生率也增加。
      • 微創神經外科的引進迅速增加
      • 提高患者對腦部疾病診斷和治療的認知
    • 抑制因素
      • MRI 導引的神經外科消融相關的高成本
    • 機會
      • 新興國家醫療保健費用快速增加
      • 與神經外科消融相關的技術進步和研究活動的增加
    • 任務
      • 缺乏熟練人才
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 MRI 導引神經外科消融市場：依產品

  • 配件
  • MRI導引聚焦超音波系統
  • MRI導引雷射消熔系統
  • MRI導引射頻消融系統

第 7 章 MRI 導引神經外科消融市場：依最終使用者分類

  • 門診手術中心
  • 診所
  • 醫院

第8章北美和南美MRI引導神經外科消融市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太MRI引導神經外科消融市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲MRI引導神經外科消融市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Monteris Medical Corporation
  • Seattle Children's Hospital
  • Siemens AG
  • SternMed GmbH
Product Code: MRR-036C5CF3A877

The MRI Guided Neurosurgical Ablation Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.07 billion in 2024, and is projected to grow at a CAGR of 4.84%, to USD 5.42 billion by 2030.

The scope of MRI Guided Neurosurgical Ablation encompasses the use of MRI technology to guide minimally invasive surgical procedures intended to ablate or remove predefined volumes of brain tissue. This technology proves essential as it allows for precise targeting of pathologies, reducing potential damage to surrounding healthy tissue, thereby enhancing patient outcomes and recovery times. Its applications are broad, spanning neurological disorders such as epilepsy, brain tumors, and Parkinson's disease, while the end-use segments mainly involve hospitals, specialty clinics, and research institutions. Key growth factors include increasing prevalence of neurological disorders, rising demand for minimally invasive surgeries, and advancements in MRI technology that improve accuracy and safety. As healthcare infrastructure develops and aging populations expand, opportunities for market growth similarly enlarge. Integrating artificial intelligence for enhanced imaging interpretation and personalized treatment planning represents a potential area for innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 3.89 billion
Estimated Year [2024] USD 4.07 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 4.84%

However, several limitations and challenges could inhibit market growth, such as high equipment costs and a demand for skilled professionals capable of operating complex technologies. Furthermore, regulatory and reimbursement challenges might impede swift market penetration, especially in developing regions with less robust healthcare systems. The highly competitive market landscape, with prominent players heavily investing in R&D, necessitates continuous innovation to maintain a competitive edge. Recommendations to seize emerging market opportunities include investments in AI-driven platform development, partnerships for broadening technology access, and expanding clinical trial programs to validate new therapeutic applications. Enhanced focus on educating both the medical community and patients about the benefits of MRI-guided procedures could drive adoption rates. Innovations should center on improving the procedural efficiency, cost-effectiveness, and therapeutic outcomes of MRI-guided ablations. A progressive approach to overcoming regulatory obstacles and addressing reimbursement issues is also crucial for sustainable growth. Given these dynamics, the market is expected to continue evolving rapidly, characterized by technological advancements and increasing adoption across more geographical regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
    • Surge in the adoption of minimally invasive neurosurgeries
    • Rise in the awareness of brain disorder diagnosis and treatment among patients
  • Market Restraints
    • High cost associated with the MRI guided neurosurgical ablation
  • Market Opportunities
    • Rapidly growing healthcare expenditures in emerging nations
    • Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
  • Market Challenges
    • Lack of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the MRI Guided Neurosurgical Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Guided Neurosurgical Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Guided Neurosurgical Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Guided Neurosurgical Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Guided Neurosurgical Ablation Market

A detailed market share analysis in the MRI Guided Neurosurgical Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Guided Neurosurgical Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Guided Neurosurgical Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Guided Neurosurgical Ablation Market

A strategic analysis of the MRI Guided Neurosurgical Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Guided Neurosurgical Ablation Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cook Group Incorporated, Monteris Medical Corporation, Seattle Children's Hospital, Siemens AG, and SternMed GmbH.

Market Segmentation & Coverage

This research report categorizes the MRI Guided Neurosurgical Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems, and MRI Guided RF Ablation Systems.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
      • 5.1.1.2. Surge in the adoption of minimally invasive neurosurgeries
      • 5.1.1.3. Rise in the awareness of brain disorder diagnosis and treatment among patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the MRI guided neurosurgical ablation
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapidly growing healthcare expenditures in emerging nations
      • 5.1.3.2. Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled manpower
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. MRI Guided Neurosurgical Ablation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. MRI Guided Focused Ultrasound Systems
  • 6.4. MRI Guided Laser Ablation Systems
  • 6.5. MRI Guided RF Ablation Systems

7. MRI Guided Neurosurgical Ablation Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas MRI Guided Neurosurgical Ablation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific MRI Guided Neurosurgical Ablation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa MRI Guided Neurosurgical Ablation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cook Group Incorporated
  • 3. Monteris Medical Corporation
  • 4. Seattle Children's Hospital
  • 5. Siemens AG
  • 6. SternMed GmbH

LIST OF FIGURES

  • FIGURE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MRI GUIDED NEUROSURGICAL ABLATION MARKET DYNAMICS
  • TABLE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED FOCUSED ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED LASER ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED RF ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023